Endocrine signaling research
GHRP-6
Péptido de investigación de señalización endocrina liofilizado para revisión de sistemas
GHRP-6 is an early growth hormone releasing peptide used as a reference point in GH secretagogue literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesFor laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, mitigate, or prevent disease.
Mantener sellado, frío, seco y protegido de los cambios de calor. Confirme el almacenamiento específico del producto a su llegada.
Empaquetado para estabilidad en tránsito con soporte de pedidos disponible para rutas en climas cálidos.
Batch-linked certificate support is available through the documentation desk.
Contexto de investigación
Perfil de investigación de GHRP-6
GHRP-6 is an early synthetic growth hormone-releasing peptide used as a reference in ghrelin-receptor and GH-secretagogue research. Experimental studies measure GH response, receptor signaling, endocrine markers, appetite-related pathways, and differences from GHRP-2, ipamorelin, hexarelin, or GHRH analogs. It is commonly chosen when a project needs a historically established GHS-R comparator with a broad physiological research record. Because secretagogues can differ in selectivity and off-target endocrine observations, compounds should not be treated as interchangeable. Findings from older human or animal studies describe their specific materials and protocols and do not establish the suitability or performance of a separate catalog product.
Mecanismo propuesto
A synthetic GHS-R1a agonist that stimulates growth-hormone release and activates central ghrelin-related appetite pathways. It also has measurable endocrine activity beyond GH in some models.
Efectos reportados en estudios
- Human and animal studies reported acute GH release and increased food intake or appetite-related signaling.
- Some studies observed increases in cortisol or prolactin, demonstrating lower endocrine selectivity than a purely GH-specific ligand.
- Responses can diminish or change with repeated exposure and depend on endogenous GHRH and somatostatin tone.
Criterios de investigación comunes
GHS-R activation, GH, ACTH, cortisol, prolactin, food intake, hypothalamic signaling, glucose, receptor desensitization, and interaction with GHRH.
Evidencia y limitaciones
The acute endocrine and appetite-related effects are documented in preclinical and human pharmacology studies. Long-term safety and product equivalence remain unestablished.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
What documentation can I request before ordering?
Before ordering, contact support with the product name, selected format, andu2014if availableu2014an order or batch reference to request available batch-linked documentation.
What should I confirm before ordering?
Compare the product name, listed amount, physical form, storage note, price, and documentation route. When the order arrives, match the product and lot or batch reference to the order record and available documentation.